Fig. 5
Cumulative incidence of CIN3+ by years of follow-up using 4 years quarantine from baseline. Comparing the women with HPV 16/18, HPV 31/33 and women with a negative HPV test
Fig. 5 | Infectious Agents and Cancer
Cumulative incidence of CIN3+ by years of follow-up using 4 years quarantine from baseline. Comparing the women with HPV 16/18, HPV 31/33 and women with a negative HPV test